ArticlePediatric research2026
Neonatal hypoglycemia and neurodevelopment outcomes among late preterm infants: a prospective cohort study.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe impact of neonatal hypoglycemia on neurodevelopment in late preterm infants is not well established. We aimed to compare neurodevelopmental outcomes at 18-24 months' corrected age in a subgroup of late preterm infants who were either euglycemic or hypoglycemic during the initial 24 h of life.
methodsWe conducted a multicenter, prospective cohort study of a subgroup of late preterm infants (≥35 weeks' gestation and ≥2000 g) who underwent risk-based screening for hypoglycemia in the newborn nursery. Infants were categorized into hypoglycemic and euglycemic cohorts. Neurodevelopment was evaluated at 18-24 months' corrected age using the Bayley Scales of Infant and Toddler Development, Fourth Edition.
resultsAmong 128 infants, no significant differences were observed in neurodevelopmental outcomes at 18-24 months' corrected age between hypoglycemic and euglycemic cohorts. These findings were consistent across cognitive, motor, language, social-emotional, and adaptive behavior domains, even after adjusting for key confounders. Subgroup analyses for severe (<36 mg/dL) and recurrent (≥3 episodes) hypoglycemia did not show any differences in neurodevelopmental outcome.
conclusionTransient neonatal hypoglycemia in late preterm infants, when identified and managed using the American Academy of Pediatrics' operational thresholds, was not associated with adverse neurodevelopmental outcomes at 18-24 months' corrected age. IMPACT: This is one of the few prospective multicenter studies assessing neurodevelopmental outcomes following neonatal hypoglycemia, focused specifically on late preterm infants. Hypoglycemia in late-preterm infants showed no impact on neurodevelopment at 18-24 months. Multicenter design and blinded assessments ensured strong study validity. The study adds population-specific evidence to the existing literature dominated by mixed gestational-age cohorts. Findings support the safety of American Academy of Pediatrics screening guidelines and treatment protocols for managing neonatal hypoglycemia in the newborn nursery.
Identifiers
42225815What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.